Bioneutra Internatio Profitability Analysis

BIMO Stock  USD 0.0001  0.00  0.00%   
Considering Bioneutra Internatio's profitability and operating efficiency indicators, Bioneutra Internatio may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Bioneutra Internatio's ability to earn profits and add value for shareholders. As of the 1st of December 2024, Price To Sales Ratio is likely to drop to 236.66. In addition to that, EV To Sales is likely to drop to 236.38. As of the 1st of December 2024, Income Quality is likely to grow to 0, while Net Loss is likely to drop (0.0005).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.630.71
Fairly Down
Slightly volatile
Return On Equity0.180.21
Fairly Down
Slightly volatile
For Bioneutra Internatio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioneutra Internatio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioneutra Internatio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioneutra Internatio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioneutra Internatio over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Bioneutra Stock, please use our How to Invest in Bioneutra Internatio guide.
Is Industrial Conglomerates space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioneutra Internatio. If investors know Bioneutra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioneutra Internatio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioneutra Internatio is measured differently than its book value, which is the value of Bioneutra that is recorded on the company's balance sheet. Investors also form their own opinion of Bioneutra Internatio's value that differs from its market value or its book value, called intrinsic value, which is Bioneutra Internatio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioneutra Internatio's market value can be influenced by many factors that don't directly affect Bioneutra Internatio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioneutra Internatio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioneutra Internatio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioneutra Internatio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bioneutra Internatio Shares Outstanding vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bioneutra Internatio's current stock value. Our valuation model uses many indicators to compare Bioneutra Internatio value to that of its competitors to determine the firm's financial worth.
Bioneutra Internatio is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about  10,001  of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioneutra Internatio's earnings, one of the primary drivers of an investment's value.

Bioneutra Current Valuation vs. Competition

Bioneutra Internatio is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Industrials industry is currently estimated at about 5.81 Billion. Bioneutra Internatio adds roughly 16,342 in current valuation claiming only tiny portion of equities under Industrials industry.

Bioneutra Shares Outstanding vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Bioneutra Internatio

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
16.34 K
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Bioneutra Internatio

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
163.43 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Bioneutra Shares Outstanding Comparison

Bioneutra Internatio is currently under evaluation in shares outstanding category among its peers.

Bioneutra Internatio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bioneutra Internatio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bioneutra Internatio will eventually generate negative long term returns. The profitability progress is the general direction of Bioneutra Internatio's change in net profit over the period of time. It can combine multiple indicators of Bioneutra Internatio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year

Bioneutra Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bioneutra Internatio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioneutra Internatio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioneutra Internatio's important profitability drivers and their relationship over time.

Use Bioneutra Internatio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioneutra Internatio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioneutra Internatio will appreciate offsetting losses from the drop in the long position's value.

Bioneutra Internatio Pair Trading

Bioneutra Internatio Pair Trading Analysis

The ability to find closely correlated positions to Bioneutra Internatio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioneutra Internatio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioneutra Internatio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioneutra Internatio to buy it.
The correlation of Bioneutra Internatio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioneutra Internatio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioneutra Internatio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioneutra Internatio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bioneutra Internatio position

In addition to having Bioneutra Internatio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alcohol Thematic Idea Now

Alcohol
Alcohol Theme
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bioneutra Internatio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioneutra Internatio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioneutra Internatio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioneutra Internatio Stock:
Check out Trending Equities.
To learn how to invest in Bioneutra Stock, please use our How to Invest in Bioneutra Internatio guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
To fully project Bioneutra Internatio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioneutra Internatio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioneutra Internatio's income statement, its balance sheet, and the statement of cash flows.
Potential Bioneutra Internatio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bioneutra Internatio investors may work on each financial statement separately, they are all related. The changes in Bioneutra Internatio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bioneutra Internatio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.